GLEN BURNIE, Md.--(EON: Enhanced Online News)--NovaSom, Inc., a leader in Obstructive Sleep Apnea (OSA) home testing solutions, and The American Sleep Apnea Association, a nonprofit organization that promotes awareness of sleep apnea, have released the results of a commissioned survey to better understand consumer awareness of OSA, its associated risks, and perceptions regarding testing and treatment. The survey, which polled over 500 American consumers, men and women, between the ages of 30 and 65, revealed a clear lack of awareness about the latest screening and testing technologies – exposing one of the likely reasons behind why 85% of the more than 43 million Americans with OSA remain undiagnosed.
“As an organization dedicated to continuing improvements in treatments for sleep apnea, we were excited to collaborate with NovaSom on this survey to better understand consumer behavior and perceptions related to OSA”
The risks associated with obstructive sleep apnea are serious and untreated OSA can reduce a person’s lifespan by 5-7 years. The survey found that while most consumers are aware of OSA, there is still a hesitance to treat it and most are unaware of how easy it is to get a risk assessment for OSA and test for it at home. Key survey findings include:
- 78% of respondents have heard of OSA and 70% have friends or family with OSA
- 76% of respondents feel that they understand the risks associated with sleep apnea
- 40% of respondents who have suspected themselves or their spouse/partner of having the condition have taken no action to get diagnosed and/or treated
- 88% of the respondents were unaware of either the Epworth or Stop-Bang questionnaires – both free and easy risk assessments for sleep apnea that can be found online
- Nearly 82% of respondents were unaware that they could test for sleep apnea with a home sleep test prescribed by their doctor
- 81% of respondents would prefer to take a home sleep test over spending a night in a sleep lab, with the top reason being the ability to sleep in their own bed
“Too many people die each year from comorbidities associated with sleep apnea, a condition that can be easily treated,” said John Spitznagel, Chief Executive Officer of NovaSom. “The results of this survey validate the need to increase consumer awareness of sleep apnea risk factors and the convenient testing options that are available through their doctor, whether ultimately ordered by a family doctor, sleep specialist, or other medical practitioner.”
Medical practitioners play an integral role in the diagnostic and treatment processes related to sleep apnea. When respondents were asked where they would go to learn more about sleep apnea, 67% said they would speak with their family doctor. Additionally, a majority (62%) of those surveyed listed education from a physician as the best way to spread the word about obstructive sleep apnea.
“As an organization dedicated to continuing improvements in treatments for sleep apnea, we were excited to collaborate with NovaSom on this survey to better understand consumer behavior and perceptions related to OSA,” said Edward Grandi, Executive Director of the American Sleep Apnea Association. “Information and awareness is key to reaching the vast numbers of affected Americans.”
“Home sleep testing is appropriate for about 80% of OSA testing, and is an excellent option due to its cost, convenience and comfort for the patient,” added Spitznagel. “If sleep apnea is suspected, testing – whether at home or at a sleep clinic – is the first step toward a longer and healthier life, not to mention a better night’s sleep. The value of our AccuSom® home sleep test is that it's easy to use, we have clinical staff on standby for telephonic patient support 24/7, and its wireless data transmission allows for fast turnaround of results, interpretations, and the start of therapy if needed.”
For the survey executive summary or to learn more about at home sleep testing, please visit www.NovaSom.com.
NovaSom, Inc. is a leader in Obstructive Sleep Apnea (OSA) home testing, with the AccuSom® home sleep test, the only comprehensively supported home sleep test that provides continuous patient support and next-day test results and interpretation for physicians. The FDA-cleared AccuSom® test is highly accurate and significantly more convenient and comfortable for the patient, compared to in-facility testing. Patients are able to test around their own schedule and can sleep in their own bed, which helps eliminate “first night” effect and improves data collection. AccuSom® is currently covered for more than 150 million commercially insured U.S. lives. NovaSom is accredited by the Joint Commission as an Ambulatory Care Sleep Diagnostic Center & Telehealth Provider, is classified by CMS as an Independent Diagnostic Testing Facility and is an Approved Out of Center Sleep Testing Supplier by the American Academy of Sleep Medicine (AASM). To learn more, please visit www.novasom.com.
About The American Sleep Apnea Association
The American Sleep Apnea Association, founded in 1990, is a 501(c)(3) nonprofit organization that promotes awareness of sleep apnea, works for continuing improvements in treatments for this serious disease, and advocates for the interests of sleep apnea patients. Our mission is simple: The American Sleep Apnea Association is dedicated to reducing injury, disability, and death from sleep apnea and to enhancing the well-being of those affected by this common disorder. The ASAA promotes education and awareness, the ASAA A.W.A.K.E. Network of voluntary mutual support groups, research, and continuous improvement of care. To learn more, please visit www.sleepapnea.org.